Although there is currently no cure for Alzheimer’s Disease (AD), there is positive news about treating this debilitating disease, according to reports from the recent Alzheimer’s Association International Conference.
Three reasons for optimism include:
1. Improved ways to diagnose AD.
2. Deeper scientific understanding about this dreaded brain disease.
3. An encouraging drug trial (BAN2401) to effectively manage AD, which is a degenerative disease causing a slow decline in memory, thinking, and reasoning skills.
The Alzheimer’s Association (AA) states, “There is a worldwide effort underway to find better ways to treat this disease, delay its onset, and prevent it from developing.”
The AA explains that Alzheimer’s is the most common cause of dementia, a general term for memory loss and other cognitive declines, serious enough to interfere with daily life. “Alzheimer’s is not a normal part of aging. The greatest known risk factor is increasing age, and most people with Alzheimer’s are 65 and older.
“In its early stages, memory loss is mild, but with late-stage AD, individuals lose the ability to carry on a conversation, and respond to their environment. Alzheimer’s is the sixth leading cause of death in the U.S. Those afflicted live an average of eight years after their symptoms become noticeable to others, but survival can range from four to 20 years, depending on age and other health conditions.”
The AA adds, “Although no current medicines can stop Alzheimer’s from progressing, they can temporarily slow the worsening of dementia symptoms and improve quality of life for sufferers and their caregivers. An early Alzheimer’s diagnosis provides people with a better chance to benefit from treatment, and participate in clinical trials to help advance research, and possibly provide individual medical benefits.”